Table 4.
Univariate HR (95%CI) | Multivariate P value HR (95%CI) P value | |||
---|---|---|---|---|
Age/years (25–79) | 1.053 (1.013–1.094) | 0.008 | ns | ns |
Tumor size/cm (0.5–22) | 0.869 (0.765–0.988) | 0.032 | ns | ns |
Pathological type (Serous vs other) | 0.116 (0.016–0.856) | 0.035 | ns | Ns |
Tumor size/cm (0.5–22) | 0.869 (0.765–0.988) | 0.032 | ns | Ns |
HRR gene status (m vs w) | 2.230 (1.019–4.880) | 0.045 | 2.979 (1.037–8.561) | 0.043 |
LVSI (- vs +) | 3.702 (1.230–11.136) | 0.020 | ns 4.085 | ns |
Postoperative targeted therapy (- vs +) | 2.406 (1.306–4.433) | 0.005 | 0.020 | (1.249–13.361) |
* LVSI, Lymphovascular space invasion; m, mutant; w, wildtype.